Monteris receives FDA clearance for NeuroBlate Optic probe

Oct 24, 2018 · Regulatory · Monteris Medical · Surgical

Monteris Medical received FDA clearance for the NeuroBlate Optic laser probe for MRI-guided robotic laser thermotherapy.

Monteris Medical company media
Company media · Monteris Medical
  • The Optic probe uses fiber-optic controlled cooling.
  • The probe is used with Monteris NeuroBlate MRI-guided robotic laser therapy.
  • At the time, NeuroBlate had been used in more than 2,000 procedures across about 60 installed systems.

Develops minimally invasive neurosurgery systems centered on the NeuroBlate platform for MRI-guided laser interstitial thermal therapy in the brain. The company combines robotic control, cooled laser probe technology, software, and treatment-planning workflow to support targeted ablation of brain lesions in adult and pediatric patients.